Monness, Crespi, Hardt analyst Brian White downgrades Salesforce (NYSE:CRM) from Buy to Neutral.
Accolade’s Financial Forecast: Anticipating Raised Guidance and Robust Revenue Growth
Needham analyst Ryan MacDonald reiterated a Buy rating on the shares of Accolade, Inc. (NASDAQ: ACCD) with a